BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7504493)

  • 21. Bleomycin: mammalian cell lethality and cellular basis of optimal schedule.
    Takabe Y; Miyamoto T; Watanabe M; Terasima T
    J Natl Cancer Inst; 1977 Oct; 59(4):1251-5. PubMed ID: 71355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combined effects of local hyperthermia, bleomycin, and x-ray on Ehrlich ascites tumor in mice].
    Kai H
    Nihon Geka Gakkai Zasshi; 1985 Aug; 86(8):901-11. PubMed ID: 2414640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demonstration of repair of potentially lethal damage in plateau phase cells of Ehrlich ascites tumor after exposure to bleomycin.
    Takabe Y; Miyamoto T; Terashima T
    Gan; 1974 Dec; 65(6):559-60. PubMed ID: 4142871
    [No Abstract]   [Full Text] [Related]  

  • 24. [Distribution of various 57Co-labelled zhengguangmycin preparations in Ehrlich carcinoma bearing mice in relation with their antitumor activity and toxicity (author's transl)].
    Xue SB; Liu HT; Zhang HQ; Li DD; Lin HY
    Yao Xue Xue Bao; 1980 Jan; 15(1):1-6. PubMed ID: 6161520
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antitumor effects of newly synthesized analogues of platinum (NK121) and bleomycin (NK313) in nude mice implanted human tumor].
    Yokoe H; Kanazawa H; Takahashi K; Sato K
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):97-101. PubMed ID: 1702964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation of the cytotoxicity of peplomycin against Ehrlich ascites carcinoma by bleomycin hydrolase inhibitors.
    Nishimura C; Nishimura T; Tanaka N; Suzuki H
    J Antibiot (Tokyo); 1987 Dec; 40(12):1794-5. PubMed ID: 2448282
    [No Abstract]   [Full Text] [Related]  

  • 27. Dolomite supplementation improves bone metabolism through modulation of calcium-regulating hormone secretion in ovariectomized rats.
    Mizoguchi T; Nagasawa S; Takahashi N; Yagasaki H; Ito M
    J Bone Miner Metab; 2005; 23(2):140-6. PubMed ID: 15750692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies on antitumor activities of bleomycin oil suspension in vivo (author's transl)].
    Abe F; Ichoda Y; Yamashita T; Yamaguchi S; Yoshioka O
    Jpn J Antibiot; 1976 Sep; 29(9):834-40. PubMed ID: 61292
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of N-(o-methoxyphenyl)-maleimide on 5-fluorouracil cytotoxicity in Ehrlich (ascites) carcinoma.
    Ambaye RY; Indap MA
    Cancer Lett; 1991 Apr; 57(1):21-6. PubMed ID: 1902758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cellular transport mechanisms for 57Co-bleomycin].
    Metelmann HR; Bier J; Bitter K
    Dtsch Zahnarztl Z; 1980 Jan; 35(1):99-101. PubMed ID: 6157514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct antitumor effect of cepharanthin and combined effect with adriamycin against Ehrlich ascites tumor in mice.
    Asaumi J; Nishikawa K; Matsuoka H; Iwata M; Kawasaki S; Hiraki Y; Nishijima K
    Anticancer Res; 1995; 15(1):67-70. PubMed ID: 7733643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of poly(adenosine diphosphate ribose) polymerase potentiate the antitumor activity of bleomycin against Ehrlich ascites carcinoma.
    Kawamitsu H; Miwa M; Tanaka Y; Sakamoto H; Terada M; Hoshi A; Sugimura T
    J Pharmacobiodyn; 1982 Nov; 5(11):900-4. PubMed ID: 6187912
    [No Abstract]   [Full Text] [Related]  

  • 33. In vivo antitumoral effect of Plantago major L. extract on Balb/C mouse with Ehrlich ascites tumor.
    Ozaslan M; Didem Karagöz I; Kalender ME; Kilic IH; Sari I; Karagöz A
    Am J Chin Med; 2007; 35(5):841-51. PubMed ID: 17963323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cytokinetic effect of bleomycin on mouse Ehrlich carcinoma in vivo. Possibilities of tumor cell synchronization for radiotherapy].
    Schumann J; Göhde W
    Strahlentherapie; 1974 Mar; 147(3):298-307. PubMed ID: 4135912
    [No Abstract]   [Full Text] [Related]  

  • 35. Amplification of the antitumor activity of phleomycins and bleomycins in rats and mice by caffeine.
    Allen TE; Aliano NA; Cowan RJ; Grigg GW; Hart NK; Lamberton JA; Lane A
    Cancer Res; 1985 Jun; 45(6):2516-21. PubMed ID: 2580623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
    Yamamoto N; Naraparaju VR
    Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental study of bleomycin therapy in combination with hyperbaric oxygenation.
    Takenaka S; Arimura T; Higashi M; Nagayama T; Ito E
    Nihon Gan Chiryo Gakkai Shi; 1980 Aug; 15(5):864-75. PubMed ID: 6159432
    [No Abstract]   [Full Text] [Related]  

  • 38. Enhancement of cytotoxicity of bleomycin by dithiocarbamates: formation of bis(dithiocarbamato) cu(II).
    Ujjani B; Lyman S; Winkelmann D; Antholine W; Petering DH; Jones MM
    J Inorg Biochem; 1990 Jan; 38(1):81-93. PubMed ID: 1692085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sildenafil potentiates the antitumor activity of cisplatin by induction of apoptosis and inhibition of proliferation and angiogenesis.
    El-Naa MM; Othman M; Younes S
    Drug Des Devel Ther; 2016; 10():3661-3672. PubMed ID: 27895461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dextran derivatives in single and combination chemotherapy against transplantable mouse ascites and solid tumors.
    Suzuki M; Mikami T; Kadowaki M; Matsumoto T; Suzuki S
    Cancer Res; 1977 Sep; 37(9):3448-54. PubMed ID: 69495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.